Clearstead Advisors, LLC Haemonetics Corp Transaction History
Clearstead Advisors, LLC
- $6.31 Billion
- Q3 2024
A detailed history of Clearstead Advisors, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Clearstead Advisors, LLC holds 1,404 shares of HAE stock, worth $108,683. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,404
Previous 65
2060.0%
Holding current value
$108,683
Previous $5,000
2140.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HAE
# of Institutions
332Shares Held
53.8MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$461 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$400 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$344 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$325 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$312 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.97B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...